Park Ha Biological Tech Files 6-K for April 2025 Period

Ticker: BYAH · Form: 6-K · Filed: Aug 26, 2025 · CIK: 1986247

Sentiment: neutral

Topics: foreign-private-issuer, financial-update, sec-filing

TL;DR

Park Ha Biological Tech dropped a 6-K update for April '25 - check financials!

AI Summary

Park Ha Biological Technology Co., Ltd. filed a Form 6-K on August 26, 2025, reporting on its operating and financial review and prospects for the period ending April 30, 2025. The company is based in Wuxi, Jiangsu Province, People's Republic of China, and operates in the soap, detergent, cleaning preparations, perfumes, and cosmetics industry.

Why It Matters

This filing provides an update on the company's financial performance and operational outlook, which is crucial for investors to assess its current standing and future prospects.

Risk Assessment

Risk Level: low — This is a routine filing providing financial and operational updates, not indicating any immediate significant risks.

Key Players & Entities

FAQ

What is the primary purpose of this Form 6-K filing?

The Form 6-K is a report of foreign private issuer filed for the month of August 2025, containing an 'Operating and Financial Review and Prospects' in connection with unaudited consolidated financial information.

What is the reporting period covered by the financial review?

The Conformed Period of Report is April 30, 2025.

Where is Park Ha Biological Technology Co., Ltd. located?

The company's principal executive offices are located at 901, Building C, Phase 2, Wuxi International Life Science Innovation Campus, 196 Jinghui East Road, Xinwu District, Wuxi, Jiangsu Province, People's Republic of China.

What is the company's Standard Industrial Classification (SIC) code and industry?

The SIC code is 2840, which corresponds to SOAP, DETERGENT, CLEANING PREPARATIONS, PERFUMES, COSMETICS.

Does the company file annual reports under Form 20-F or Form 40-F?

The registrant indicates it files annual reports under cover of Form 20-F.

Filing Stats: 268 words · 1 min read · ~1 pages · Grade level 10.2 · Accepted 2025-08-26 07:01:39

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Park Ha Biological Technology Co., Ltd. Date: August 26, 2025 By: /s/ Xiaoqiu Zhang Name: Xiaoqiu Zhang Title: Chief Executive Officer, Chairperson of the Board of Directors 2

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing